ASA: Green Light Therapy for Pain-Related Anxiety Studied in Fibromyalgia
Small study suggests green light therapy might reduce anxiety in patients with fibromyalgia who are taking opioids for chronic pain
Fibromyalgia
MPR Weekly Dose Podcast #133
ALS treatment news; Evusheld fact sheet update; an at-home epilepsy diagnostic aid gets cleared; drug recalls; and a laser therapy for fibromyalgia.
FibroLux Laser Therapy Cleared to Treat Pain Associated With Fibromyalgia
The FDA cleared the device based on data from a placebo-controlled, randomized, double-blind, parallel group clinical study.
Wearable TENS Device Cleared for Fibromyalgia Treatment
The Quell® neuromodulation device (NeuroMetrix) has received the Food and Drug Administration De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia in adults with high pain sensitivity. Quell is a transcutaneous electrical nerve stimulator (TENS) that is worn on the upper calf. The device delivers electrical stimulation to the user…
Enrollment in Fibromyalgia Treatment Study Ends After Disappointing Results
The phase 3 RALLY study is evaluating the efficacy and safety of TNX-102 SL in 514 adult patients with fibromyalgia.
Evidence Lacking for Most Fibromyalgia Therapies
To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.
Evidence Supporting Use of Compounded Topical Pain Creams Limited
“In context of the recent rise in supply and demand of compounded preparations, lack of evidence regarding systemic absorption of ingredients used in compounded topical pain creams gives rise to a substantial public health concern,” the authors concluded.
Cymbalta Approved for Pediatric Patients With Fibromyalgia
The Food and Drug Administration (FDA) has expanded the approval of Cymbalta (duloxetine; Lilly) to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.
Nonopioid Drug Therapies Evaluated for Chronic Pain
Various electronic databases were accessed to obtain randomized controlled trials (RCTs) evaluating nonopioid agents in chronic pain patients. The review focused on 7 chronic pain conditions, including neuropathic pain, fibromyalgia, osteoarthritis, inflammatory arthritis, low back pain, chronic headache, and sickle cell disease.
Four Weeks of Active TENS Beneficial for Fibromyalgia
Greater decline seen in movement-evoked pain, fatigue; more improvement found on global impression of change
